Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours

Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer

Lower-income Patients are less likely to participate in clinical trials

Bendamustine regimen more effective for lymphoma than standard CHOP

Early results from new PD-1 targeted immune therapy

New study asks patients preference on kidney cancer treatment

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival

Problems in the structure of clinical trials

Transfer of information through EurocanPlatform

Primary and secondary resistance in colorectal cancer

Analysing changes in the pharmaceutical industry

Economics of treating patients